Stay updated on PEACOCC Clinical Trial
Sign up to get notified when there's something new on the PEACOCC Clinical Trial page.

Latest updates to the PEACOCC Clinical Trial page
- Check3 days agoChange DetectedThe study record for the pembrolizumab trial is displayed, with its design, eligibility criteria, outcome measures, completion details, publication, and supporting study documents.SummaryDifference44%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA site-wide NIH notice about terminology during a website transition appears above the 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe footer revision identifier updates from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study record content. This blocks access to the trial details and related information.SummaryDifference15%

- Check58 days agoChange Detected- The page shows a new revision tag: v3.7.0, replacing the previous v3.6.6, indicating a minor release of the page. The change reflects an update to the page's metadata/UI without altering the study data shown.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a small version update to the site's revision labeling rather than an update to trial content or features.SummaryDifference0.1%

Stay in the know with updates to PEACOCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEACOCC Clinical Trial page.